FGSKX
Price
$49.27
Change
+$0.05 (+0.10%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

FGSKX vs RPMGX

Header iconFGSKX vs RPMGX Comparison
Open Charts FGSKX vs RPMGXBanner chart's image
Federated Hermes MDT Mid Cap Growth R6
Price$49.27
Change+$0.05 (+0.10%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FGSKX vs RPMGX Comparison Chart
Loading...
VS
FGSKX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGSKX is a Buy and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. FGSKX (1.69B). RPMGX pays higher dividends than FGSKX: RPMGX (0.05) vs FGSKX (0.00). FGSKX was incepted earlier than RPMGX: FGSKX (18 years) vs RPMGX (32 years). FGSKX is a more actively managed with annual turnover of: 142.00 vs. RPMGX (21.70). FGSKX has a lower initial minimum investment than RPMGX: FGSKX (0) vs RPMGX (2500). FGSKX annual gain was more profitable for investors over the last year : 36.52 vs. RPMGX (14.65). FGSKX return over 5 years is better than : 26.33 vs. RPMGX (14.51).
FGSKXRPMGXFGSKX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years32 years-
Gain YTD18.6949.026207%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.69B31.4B5%
Annual Yield % from dividends0.000.05-
Returns for 1 year36.5214.65249%
Returns for 3 years-11.67-13.8185%
Returns for 5 years26.3314.51181%
Returns for 10 years7.0643.2916%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences